The efficacy and tolerability of long-term cabergoline therapy in hyperprolactinaemic disorders an open, uncontrolled, multicentre study

• Main Authors: Ismail, I.S., Webster, J., Piscitelli, G., Polli, A., D'Alberton, A., Falsetti, L., Ferrari, C., Fioretti, P., Giordano, G., L'Hermite, M., Ciccarelli, E., Crosignani, P.G., DeCecco, L., Fadini, R., Faglia, G., Flamigni, C., Tamburrano, G., Scanlon, M.F.
• Format: Article
• Language: English
• Published: Wiley 1993
• Subjects: R Medicine (General)
• Online Access: http://eprints.um.edu.my/10455/1/The_efficacy_and_tolerability_of_long-term.pdf; http://eprints.um.edu.my/10455/

We assessed the efficacy and safety of the new, long-acting dopamine agonist drug cabergoline during long-term therapy of hyperprolactinaemia. Open, prospective, multicentre study. One hundred and sixty-two females with either a microprolactinoma (n =loo), idiopathic hyperprolactinaemia (n = 54), e...